• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.31% Nasdaq Up 0.86%

    Clovis Oncology, Inc. (CLVS)

    -NasdaqGS
    56.29 Up 1.71(3.13%) 3:07PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:54.58
    Open:54.53
    Bid:56.24 x 100
    Ask:56.30 x 100
    1y Target Est:84.89
    Beta:2.4
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:54.53 - 56.90
    52wk Range:35.33 - 93.33
    Volume:117,056
    Avg Vol (3m):759,756
    Market Cap:1.91B
    P/E (ttm):N/A
    EPS (ttm):-4.03
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLVS

    Comparison

    Symbol% ChgMkt Cap
    CLVSUp 3.13%1.91B
    IMMUUp 0.50%412.78M
    LRUSF 0.00%N/A
    THLDUp 4.44%192.01M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):136.06
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Dec-14) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback